Comorbidities, meds factor into recurrent syncope

Comorbidities, meds factor into recurrent syncope

(HealthDay)—Certain comorbidities, age, gender, and use of multiple medications that cause orthostatic hypotension are associated with increased risk of recurrent syncope, according to research published in the Nov. 15 issue of The American Journal of Cardiology.

Martin Huth Ruwald, M.D., Ph.D., of Gentofte Hospital in Hellerup, Denmark, and colleagues analyzed data from 2001 to 2009 for patients older than 50 years, who were discharged after an initial episode of syncope, to assess the predictive factors for recurrent syncope.

The researchers found that patients with syncope who were 85 years or older were more often women (65 versus 47 percent) and, in general, had more non-cardiovascular comorbid conditions. The prevalence of cardiovascular comorbidities was distributed across age groups. Baseline predictors that were significantly associated with recurrent syncope included (hazard ratio [HR], 1.48), impaired renal function (HR, 1.34), atrioventricular or left bundle branch block (HR, 1.32), male gender (HR, 1.18), chronic obstructive pulmonary disorder (HR, 1.10), heart failure (HR, 1.10), atrial fibrillation (HR, 1.09), age per five-year increment (HR, 1.09), and each increase in medications that cause orthostatic hypotension (HR, 1.06).

"The use of multiple orthostatic medications additively increased the risk of recurrences, representing a need for strategies to reduce unnecessary polypharmacy," the authors write.

One author received independent research scholarship funds from the Novo Nordisk Foundation.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Risk of comorbidities up with hypoglycemia in T2DM

Apr 08, 2013

(HealthDay)—For patients with type 2 diabetes, hypoglycemia, regardless of its severity, correlates with a significantly increased risk of cardiovascular events, all-cause hospitalization, and mortality, ...

Recommended for you

Study shows who benefits most from statins

17 hours ago

New research suggests that widely used statin therapy provides the most benefit to patients with the highest genetic risk of heart attack. Using a relatively straightforward genetic analysis, the researchers ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.